Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA Advisory Panel To Review New Heart Failure Drug From Novartis
FDA Advisory Panel To Review New Heart Failure Drug From Novartis
FDA Advisory Panel To Review New Heart Failure Drug From Novartis
Submitted by
admin
on January 7, 2014 - 12:26pm
Source:
Forbes
News Tags:
FDA
advisory panels
Novartis
serelaxin
heart failure
Headline:
FDA Advisory Panel To Review New Heart Failure Drug From Novartis
Do Not Allow Advertisers to Use My Personal information
